Skip to content

MS Morgan Stanley

S&P 500
Neutral · 57/100
Financials
Investment Banking & Brokerage

$180.57

▼ 0.8%

Updated Oct 16, 2:25 PM ET

Report Card

MS at a glance — five pillars scored 0–100 from real filed financials.

How the 0–100 rating is calculated
Value
65
Growth
77
Profitability
52
Health
0
Dividends
52

Overall: Neutral · 57/100. A wider, greener shape means more pillars look healthy. Dividends scores 0 when a company pays none — that is a choice, not a flaw.

Price — Past Year

▲ Up 68.4% in the year to Jul 6, 2026

Price 50-day average 200-day averageSource: Yahoo Finance · chart data as of Jul 6, 2026

Key Metrics

Market Cap

$337.43B

P/E

15.71x

Forward P/E (est.)

12.23x

ROE

16.3%

Revenue Growth

12.3%

EPS Growth

28.4%

Profit Margin

14.6%

FCF Yield

3.7%

Debt / Equity

7.9x

ROIC

—

Interest Coverage

—

Current Ratio

—

Dividend Yield

1.8%

Implied Growth (rev. DCF)

—

Rating Score

57/100

Business Overview

Research

Morgan Stanley (MS) is a mega-cap company in the Investment Banking & Brokerage industry, part of the Financials sector of the S&P 500, with a market value around $337.43B.

Our model rates MS Neutral (57/100) on growth, profitability, financial health, and valuation. The summary below is built from its filed financials and current ratios and refreshes automatically.

Technical Analysis (Educational)

Research

Technical analysis reads price and volume to judge momentum and timing. It complements the fundamentals above — it does not replace them. Here is what MS's chart says today, with each tool explained.

Trend — moving averages. A moving average is the average closing price over a window, which smooths out daily noise. MS trades near $180.57, around its 50-day average ($203.85) and 200-day average ($178.45). Price tangled in its moving averages means there is no clear trend — the stock is ranging.

Momentum — RSI. The Relative Strength Index runs 0–100 and measures how strong recent gains are versus losses. Above 70 is "overbought", below 30 "oversold". At 51 it is in neutral territory — neither stretched nor washed out.

MACD. MACD compares two moving averages to flag shifts in momentum. Its histogram is currently negative — short-term momentum is fading.

Volatility — ATR. Average True Range is the typical daily move. MS's is $6.08 (~3.4% of price), so swings of about that size each day are normal — handy for setting a stop that isn't too tight.

Support & resistance. In the month to Jul 6, 2026, MS found buyers near $205.83 (support) and sellers near $230.47 (resistance); its 52-week range then was $135.26–$230.47. A decisive break beyond either edge often marks the next move.

Volume. The latest session traded 0.6× the 20-day average — lighter than usual, so the move carries less conviction. Rising volume on up-days suggests real buying; on down-days, real selling.

Educational information to help you read a chart — not a recommendation or a forecast. The indicators were last computed on Jul 6, 2026; the price is current.

Metrics vs. Sector Range

Where MS sits versus the Financials companies we cover.

TTM P/E
15.7xFair
Forward P/E
12.2xFair
P/S ratio
2.9xFair
Revenue growth
12.3%Average
EPS growth
28.4%Average
Gross margin
55.6%Average
Net margin
14.6%Average
ROE
16.3%Average

Bands show the middle half (25th–75th percentile) of the 141 Financials companies in our coverage that have fundamentals data — the peer-relative anchor professional comps analysis uses. Context only — not investment advice.

Sector Peer Comparison

How MS stacks up against its Financials peers — valuation, profitability, and growth versus the sector median.

Among the 141 rated Financials companies we cover, MS ranks #96 by our overall rating. It trades at roughly in line versus the sector on earnings (15.7x P/E vs. 14.9x median) with a higher return on equity (16.3% vs. 13.6%) and slower revenue growth (12.3% vs. 15.9%).

P/E vs sector

15.7x

median 14.9x

ROE vs sector

16.3%

median 13.6%

Growth vs sector

12.3%

median 15.9%

Sector rank

#96

of 141 rated

CompanyP/ERev Gr.Rating
MSThis stock15.7x12.3%Neutral· 57
GS14.3x1.3%Neutral· 49
SCHW16.9x8.1%Favorable· 66
IBKR134.8x12.9%Neutral· 48
HOOD48x41.5%Favorable· 63
RJF14.2x5.3%Neutral· 47
HSBC14.9x109.1%Favorable· 68
RY18.2x135.3%Strong· 73
Financials median14.9x15.9%64/100

Valuation vs. quality map

sector medianGSSCHWIBKRHOODRJFHSBCRYMSP/E — cheaper ←→ pricierROE — more profitable ↑

The sweet spot is upper-left: more profitable (higher ROE) for a lower P/E. Dashed lines mark the sector median.

Compare side by side

Peers are the closest Financials companies by sub-industry and size, preferring ones with full data. Sector medians and rank use the 141 rated companies among the 289 Financials stocks we cover. Educational, not a recommendation.

Bull Case

The case for MS:

  • Revenue is growing 12.3% a year, a sign of real demand.
  • Strong return on equity (16.3%) shows capital is put to work well.

Bear Case

The case against MS:

  • Elevated leverage (debt/equity 7.9x) adds financial risk.
  • Like any single stock, it is exposed to competition, the economic cycle, and shifts in its end markets.

Key Risks

Research

Balance-sheet risk — debt/equity of 7.9x magnifies the impact of higher rates or weaker earnings.

Market risk — sector rotation, the economic cycle, and broad sentiment move the stock regardless of fundamentals.

Investment Thesis

Research

On balance, the picture is mixed: Morgan Stanley is a mega-cap financials business still growing nicely, with solid profitability, and a heavier debt load to watch. It trades at 15.7x earnings, which our model scores Neutral (57/100). Weigh this against your own goals and time horizon — this is educational information, not a recommendation.

Analyst Ratings

What 33 Wall Street analysts covering MS recommend (September 2026). Consensus is a useful sanity check — not a substitute for your own homework.

Buy
consensus · score 3.8 / 5 across 33 analysts
Strong Buy 8Buy 12Hold 12Sell 0Strong Sell 1

Analysts have turned more positive over the last three months (+4 pts of buy ratings).

Latest SEC Filings

MS's most recent filings, straight from SEC EDGAR. Annual and quarterly reports are the deep dives; 8-Ks flag material events the moment they happen. How to read a 10-K

MS — frequently asked questions

Is MS a good stock to buy?

We don't give buy or sell advice. Our model rates Morgan Stanley Neutral (57/100) based on its growth, profitability, financial health, and valuation — use that as a research starting point and make your own decision.

What is MS's rating on The Stocks School?

Morgan Stanley currently scores 57/100 (Neutral) on our transparent model, which weighs real fundamentals: growth, margins, returns on capital, balance-sheet strength, and valuation.

How our ratings work →
Where does MS's data come from?

Live price data plus real fundamentals and 5-year financials pulled directly from Morgan Stanley's SEC filings — refreshed automatically, not hand-entered.

How is the 5-year projection for MS calculated?

It's a scenario model. It starts from the latest annual revenue and net margin in SEC filings, grows revenue at an assumed rate (trailing revenue growth by default), and applies a P/E range built around today's multiple to show the resulting share-price range. When a stock has no growth or P/E data, the starting values are placeholders. It's a tool for thinking, not a prediction.

Is this MS analysis financial advice?

No. Everything on this page is educational research, not financial advice or a recommendation to buy or sell MS. Always do your own research and consider a licensed professional.

Data notice. Fundamentals and financial statements are sourced from company filings (SEC EDGAR) and market-data providers; prices and market caps refresh on trading days and may be delayed. Ratings, projections, technical signals, and written summaries are model- or rule-generated for education and may simplify or lag the latest filings.

Not advice. Nothing on this page is investment advice or a recommendation to buy, hold, or sell any security. Do your own research and consult a licensed financial professional before investing.